Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Lehmann

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2026
Placental transfer characteristics and functional impact of SGLT2 inhibitors in human experimental modelsSabrina Kuoni, Alexandra Dolder, Roger Lehmann, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 23, 2024
Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: An ex vivo human placenta perfusion and in vitro studySabrina Kuoni, Regula Steiner, Lanja Saleh, et al.
Swiss Medical Weekly|March 6, 2015
Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gainDaniela Riebenfeld, David Spirk, Alexandra Mathis, et al.
BMJ Open Diabetes Research & Care|June 20, 2024
Assessing the use of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and chronic kidney disease in tertiary care: a SwissDiab StudyPascale Sharon Hösli, Frida Renström, Markus Laimer, et al.
Swiss Medical Weekly|April 3, 2023
Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023)Giacomo Gastaldi, Barbara Lucchini, Sebastien Thalmann, et al.
The American Journal of Clinical Nutrition|October 9, 2007
Fructose intake is a predictor of LDL particle size in overweight schoolchildrenIsabelle Aeberli, Michael B Zimmermann, Luciano Molinari, et al.
Molecular and Cellular Biochemistry|July 25, 2018
Bacterial supernatants elevate glucose-dependent insulin secretion in rat pancreatic INS-1 line and islet β-cells via PI3K/AKT signalingLiza L Ramenzoni, Richard A Zuellig, Abbas Hussain, et al.
Acta Ophthalmologica|October 27, 2019
Ganglion cell layer thickening in well-controlled patients with type 1 diabetes: an early sign for diabetic retinopathy?Bianca S Gerendas, Katja Hatz, Alexandra Kaider, et al.
Cell Transplantation|March 26, 2005
Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemiaMauro Giuliani, Wolfgang Moritz, Elvira Bodmer, et al.
Digital Health|October 21, 2024
Feasibility of an exergaming training program in type 2 diabetes mellitus: A mixed method studyNikola Savic, Heidi Petry, Eling D de Bruin, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2026
Placental transfer characteristics and functional impact of SGLT2 inhibitors in human experimental modelsSabrina Kuoni, Alexandra Dolder, Roger Lehmann, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 23, 2024
Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: An ex vivo human placenta perfusion and in vitro studySabrina Kuoni, Regula Steiner, Lanja Saleh, et al.
Swiss Medical Weekly|March 6, 2015
Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gainDaniela Riebenfeld, David Spirk, Alexandra Mathis, et al.
BMJ Open Diabetes Research & Care|June 20, 2024
Assessing the use of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and chronic kidney disease in tertiary care: a SwissDiab StudyPascale Sharon Hösli, Frida Renström, Markus Laimer, et al.
Swiss Medical Weekly|April 3, 2023
Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023)Giacomo Gastaldi, Barbara Lucchini, Sebastien Thalmann, et al.
The American Journal of Clinical Nutrition|October 9, 2007
Fructose intake is a predictor of LDL particle size in overweight schoolchildrenIsabelle Aeberli, Michael B Zimmermann, Luciano Molinari, et al.
Molecular and Cellular Biochemistry|July 25, 2018
Bacterial supernatants elevate glucose-dependent insulin secretion in rat pancreatic INS-1 line and islet β-cells via PI3K/AKT signalingLiza L Ramenzoni, Richard A Zuellig, Abbas Hussain, et al.
Acta Ophthalmologica|October 27, 2019
Ganglion cell layer thickening in well-controlled patients with type 1 diabetes: an early sign for diabetic retinopathy?Bianca S Gerendas, Katja Hatz, Alexandra Kaider, et al.
Cell Transplantation|March 26, 2005
Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemiaMauro Giuliani, Wolfgang Moritz, Elvira Bodmer, et al.
Digital Health|October 21, 2024
Feasibility of an exergaming training program in type 2 diabetes mellitus: A mixed method studyNikola Savic, Heidi Petry, Eling D de Bruin, et al.
Pageof 6